RT Journal Article
SR Electronic
T1 Genetic factors affecting immune phenotypes in type 1 diabetes
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.06.21264056
DO 10.1101/2021.12.06.21264056
A1 Chu, Xiaojing
A1 Janssen, Anna W.M.
A1 Koenen, Hans
A1 Chang, Linzhung
A1 He, Xuehui
A1 Joosten, Irma
A1 Stienstra, Rinke
A1 Kuijpers, Yunus
A1 Wijmenga, Cisca
A1 Xu, Cheng-Jian
A1 Netea, Mihai
A1 Tack, Cees J.
A1 Li, Yang
YR 2022
UL http://medrxiv.org/content/early/2022/01/21/2021.12.06.21264056.abstract
AB Large inter-individual variability in immunological cell composition and function determines immune responses in general and susceptibility to immune-mediated diseases in particular. While much has been learned about the genetic variants relevant for type 1 diabetes, the pathophysiological mechanisms through which these variations exert their effects are unknown. In this study, we characterize the genetic factors influencing immune responses in patients with type 1 diabetes. Genetic variants that determine susceptibility to T1D significantly affect T cell composition. Specifically, the CCR5+ regulatory T cells associate with T1D through the CCR region, suggesting a shared genetic regulation. Genome-wide quantitative trait loci (QTL) mapping analysis of immune traits revealed 15 genetic loci that influence immune responses in T1D. Among them, 12 have never been reported in healthy population studies, implying a disease-specific genetic regulation. Altogether this study provides new insights into the genetic factors that affect immunological responses in T1D.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNo clinical trial included in this study.Funding StatementThis work was supported by an ERC starting Grant (no. 948207) and a Radboud University Medical Centre Hypatia Grant (2018) to Y.L. and an ERC advanced grant (no. 833247) and a Spinoza grant of the Netherlands Association for Scientific Research to M.G.N. C.T received funding from the Perspectief Biomarker Development Center Research Programme, which is (partly) financed by the Netherlands Organisation for Scientific Research (NWO). AJ was funded by a grant from the European Foundation for the Study of Diabetes (EFSD/AZ Macrovascular Programme 2015). X.C was supported by China Scholarship Council.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The 500FG-DM study was approved by the ethical committee of Radboud University Nijmegen (NL-number: 54214.091.15). Experiments were conducted according to the principles expressed in the Declaration of Helsinki. Written informed consent was obtained from all participants.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesResults reported in the manuscript has been summarised in supplementary tables. Codes for generating all results could be found at github (https://github.com/Chuxj/Gf_of_ip_in_T1D). Raw immune phenotype data (cell proportion and cytokine production in 300DM) and summary statistics could be found at Dryad (https://doi.org/10.5061/dryad.4f4qrfjd0). Genetics and donor information that could compromise research participant privacy are only vailable upon request to the corresponding authors (http://hfgp.bbmri.nl). http://hfgp.bbmri.nl https://github.com/Chuxj/Gf_of_ip_in_T1D https://doi.org/10.5061/dryad.4f4qrfjd0